Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Medicare may best Medicare Advantage at reducing readmissions

    June 25, 2019

    Editorialists provide reasons to exercise caution when interpreting the results.

  • 1
    News

    What drives intensification of antihypertensive therapy at discharge?

    June 25, 2019

    Are decisions to intensify antihypertensive medication regimens appropriate in older hospitalized adults?

  • 1
    News

    Rivaroxaban tied to higher GI bleeding than other NOACs

    June 17, 2019

    SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.

  • News

    Medicaid expansion associated with lower cardiovascular mortality

    June 6, 2019

    Counties in states that expanded Medicaid coverage had a significantly smaller increase in cardiovascular mortality rates in middle-aged adults, compared with nonexpansion counties.

  • News

    Lipoprotein(a) levels can guide CV risk assessment and treatment

    June 5, 2019

    High levels of Lp(a) are an independent risk factor for atherosclerotic cardiovascular disease and could be used to guide risk assessment and treatment.

  • 1
    News

    DOACs surpass warfarin in low-weight AFib patients

    June 5, 2019

    SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.

  • 1
    News

    Restrictive transfusion strategy in cardiac surgery remains noninferior

    May 24, 2019

    Does using a restrictive transfusion strategy with patients undergoing cardiac surgery affect long-term outcomes?

  • News

    AFib on the rise in end-stage COPD patients hospitalized for exacerbations

    May 18, 2019

    The prevalence of AFib among patients with end-stage COPD on home oxygen who were admitted with COPD exacerbations increased from 12.9% in 2003 to 21.3% in 2014.

  • 1
    News

    Add magnesium to treatment of AF with rapid ventricular response

    May 16, 2019

    Is magnesium a useful addition to atrioventricular (AV) nodal blockers in achieving faster rate control for atrial fibrillation (AF) with rapid ventricular response in emergency department patients?

  • 1
    News

    Aspirin shows little benefit for primary prevention of vascular disease in diabetes

    May 15, 2019

    Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?

Previous1 … 46 47 48 49 50 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences